Mark Stenhouse Transaction History

Date Transaction Value Shares Traded Form
Jun 16 2023
SELL
Sale (or disposition) back to the issuer
-
14,000
Jun 01 2023
BUY
Other acquisition or disposition
-
14,000

Also insider at

PHAT
Phathom Pharmaceuticals, Inc. Healthcare
MS

Mark Stenhouse

Chief Operating Officer
San Diego, CA

Track Institutional and Insider Activities on RXDX

Follow Prometheus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXDX shares.

Notify only if

Insider Trading

Get notified when an Prometheus Biosciences, Inc. insider buys or sells RXDX shares.

Notify only if

News

Receive news related to Prometheus Biosciences, Inc.

Track Activities on RXDX